The value of drain fluid amylase as a predictor of postoperative pancreatic fistula after pancreaticogastrostomy

ANZ J Surg. 2022 Mar;92(3):419-425. doi: 10.1111/ans.17399. Epub 2021 Nov 30.

Abstract

Background: Drain fluid amylase is commonly used as a predictor of pancreatic fistula after pancreaticoduodenectomy (PD). This study aimed to determine the ideal cut-off value of drain fluid amylase on postoperative day 1 (DFA1) for predicting pancreatic fistula after pancreaticogastrostomy (PG).

Methods: Prospective data of 272 consecutive patients undergoing PG between 2010 and 2020 was collected and analysed to determine the postoperative pancreatic fistula (POPF) risk factors.

Results: The incidence of POPF was 143 cases (52.6%). The median DFA1 in patients with POPF was significantly higher than that of patients with NO-POPF (5483 versus 311, P < 0.001). DFA1 correlated with POPF in the area under the curve (AUC) of 0.84 (P < 0.001). When DFA1 was 2300 U/L, Youden index was the highest, with a sensitivity of 72.7% and a specificity of 82.9%. Logistic regression analysis showed that DFA1 ≥ 2300 U/L was an independent predictor of POPF (P < 0.001; OR: 12.855; 95% CI: 7.019-23.544). The AUC of DFA1 and clinically relevant postoperative pancreatic fistula (CR-POPF) was 0.674 (P < 0.001).

Conclusion: DFA1 ≥ 2300 U/L can be used as an independent predictor of POPF after PG. DFA1 ≥ 3000 U/L can predict the occurrence of CR-POPF, when DFA1 ≥ 3000 U/L, the patients should be observed closely active for complications.

Keywords: drain fluid amylase; pancreatic fistula; pancreaticoduodenectomy; pancreaticogastrostomy; relevant postoperative pancreatic fistula.

MeSH terms

  • Amylases*
  • Drainage / adverse effects
  • Humans
  • Pancreatic Fistula* / diagnosis
  • Pancreatic Fistula* / epidemiology
  • Pancreatic Fistula* / etiology
  • Pancreaticoduodenectomy / adverse effects
  • Postoperative Complications / diagnosis
  • Postoperative Complications / epidemiology
  • Postoperative Complications / etiology
  • Prospective Studies
  • Risk Factors
  • Treatment Outcome

Substances

  • Amylases